Nov 15, 2026 · Sports, Health & Nutrition Daily Digest
A roundup of sports-fitness, wellness, and nutrition developments compiled for Nov 15, 2026, with summaries, links, and brief commentary.
I. Nutrition & Diet
1. DIRECT-PLUS secondary analysis: Green-Mediterranean diet linked to ~14% relative drop in pancreatic fat (nutrition/metabolism)
Summary:
A secondary MRI analysis from the Ben-Gurion University–led DIRECT-PLUS trial, published in The American Journal of Clinical Nutrition and covered around Nov 15 by EurekAlert and Chinese outlets, assigned ~294 adults with abdominal obesity/dyslipidemia to healthy dietary guidelines (HDG), a Mediterranean diet (MED), or a Green-MED pattern (walnuts plus green tea and Mankai). About 290 had eligible baseline MRI and 233 completed 18-month imaging. Relative pancreatic-fat reductions were ~−14% on Green-MED (absolute ~−2.41 percentage points), ~−6.7% on MED, and ~−0.8% on HDG; pancreatic volume did not differ significantly across groups. Greater pancreatic-fat loss tracked with better waist and insulin-resistance markers even after adjusting for visceral-fat/weight change. This was a post hoc secondary analysis in a mostly middle-aged male sample and does not prove any single food “clears the pancreas” or prevents diabetes.
Links:
- AJCN — Green-MED and pancreatic fat (DIRECT-PLUS secondary analysis)
- EurekAlert — Green Mediterranean diet and pancreatic fat
Commentary:
For people with metabolic risk, a polyphenol-rich Mediterranean pattern with fewer refined carbs and less red/processed meat is more actionable than chasing Mankai alone—and MRI fat loss is not a diabetes cure.
2. Lancet Planetary Health modelling: dairy-to-plant swaps could push teen girls’ iodine inadequacy toward ~80% (nutrition/evidence)
Summary:
University of Surrey and Queen’s University Belfast researchers modelled UK National Diet and Nutrition Survey intakes (3,500+ people, ages 18 months–100 years) against 289 commercial plant-based dairy alternatives in The Lancet Planetary Health, with further coverage on Nov 15. Under current market fortification, replacing 20%–35% of dairy raised iodine inadequacy among females 14–18 from ~54% to ~65%, and among women 19–49 from ~32% to ~42%; full replacement reached ~80% in adolescent females and ~72% in adolescent males. Only ~12% of surveyed products were iodine-fortified. Mandatory fortification of plant alternatives plus iodine-fortified bread was the most effective modelled policy package. This is scenario modelling, not a prospective intervention trial.
Links:
- The Lancet Planetary Health — plant-based dairy alternatives and micronutrient modelling
- University of Surrey — dairy replacement may raise deficiency risk
Commentary:
When swapping to oat milk or plant yogurt, check labels for iodine, calcium, and B12—adolescents and people planning pregnancy should not assume “plant” equals dairy-equivalent micronutrients.
3. RESET for Remission: very-low-energy diet plus supervised exercise achieved ~54% early-onset T2D remission at 24 weeks (nutrition/training)
Summary:
An open-label, blinded-endpoint RCT across three England/Canada centres, published in The Lancet Regional Health – Americas and widely covered on Nov 15, enrolled 96 adults aged 18–45 with obesity and early-onset type 2 diabetes not on insulin. The intervention used 800–900 kcal/day for 12 weeks plus twice-weekly supervised aerobic/resistance and one independent session, then a maintenance diet with independent exercise for weeks 13–24; controls received usual care. Remission at 24 weeks (HbA1c <6.5% without glucose-lowering drugs for ≥12 weeks) occurred in 27/50 (54%) vs 2/46 (4%); adjusted OR ~21.6. The intervention arm lost more weight with reports of better lean-mass preservation; adverse events were mostly early LED-related and self-limiting. There was no diet-only arm, and extreme calorie targets are not for unsupervised DIY use.
Links:
- Lancet Regional Health Americas — RESET for Remission trial
- McGill — half of young adults reached remission with diet and exercise
Commentary:
Medically supervised calorie deficit plus structured exercise can change disease trajectory—but everyday practice should pursue doctor-guided sustainable weight loss and strength training, not an 800-kcal copycat.
II. Exercise & Training Science
4. Nature Medicine: thrice-weekly resistance training blunted lean-tissue loss and raised strength on tirzepatide (training/obesity drugs)
Summary:
In a 40-week two-arm RCT from the University of Western Australia and collaborators, 120 adults with overweight/obesity all received tirzepatide (most titrated to 15 mg weekly) and were randomized to thrice-weekly resistance exercise or usual activity; results appear in Nature Medicine with a November UWA release. Total weight loss was similar (~−22.3 vs −22.6 kg) and fat-mass loss similar, but total lean soft-tissue loss was −4.67 kg on drug alone vs −3.57 kg with resistance training (between-group difference ~1.09 kg, P<0.001). Bench press, lat pulldown, and knee-extension strength fell on tirzepatide alone but rose ~+4.7, +8.6, and +5.9 kg with training. The sample was mainly ages 50–70 without type 2 diabetes; falls/fractures were not reported as hard endpoints.
Links:
- Nature Medicine — resistance exercise during tirzepatide therapy
- UWA — resistance training helps maintain muscle function during GLP-1 weight loss
Commentary:
If you use a GLP-1/dual agonist for weight loss, treat several weekly full-body resistance sessions plus adequate protein as standard care—not something to add after muscle is already gone.
5. High-intensity resistance training: 50% more weekly sets did not buy greater 4-week performance gains (training/dose)
Summary:
Calandrini et al. in the International Journal of Exercise Science randomized 30 recreationally trained young adults to 4 (G4; two sessions/week) or 6 (G6; three sessions/week) weekly HIRT sets per muscle group for 4 weeks. G6 accumulated ~67% higher total training volume but showed no significant between-group advantage in muscle performance, while creatine kinase, creatinine, and LDH rose more in G6. Authors recommend the lower volume under this intense protocol to avoid unnecessary physiological stress. The sample was small and the intervention short, so it does not rule out longer-term progressive volume.
Links:
Commentary:
On high-intensity templates, “one more set” is not automatically faster progress—protect technique and recovery before stacking volume.
6. Meta-analysis: proprioceptive/balance training linked to ~34% lower relative ankle-injury occurrence in athletes (training/injury prevention)
Summary:
A BMC Musculoskeletal Disorders systematic review pooled 15 randomized or cluster-randomized trials of proprioceptive training alone or as an identifiable component of multicomponent programmes (search through June 5, 2026). The pooled relative effect was ~0.659 (95% CI 0.558–0.778; I²≈22.7%), about a 34% relative reduction in ankle-injury occurrence. Subgroup interactions by sport (soccer vs other) and by standalone vs multicomponent composition were not statistically significant. Overall certainty was rated moderate; optimal dose and generalizability across levels still need work.
Links:
Commentary:
Add single-leg balance or unstable-surface work to warm-ups for jump/cut sports—cheap insurance that does not wait for the first sprain.
III. Public Health & Disease Prevention
7. CDC MMWR: ~1 in 10 U.S. adults used a GLP-1 in the past year; nearly half altered how they took it (public health/medication behavior)
Summary:
Using CDC’s Rapid Surveys System (July–August 2025; ~8,118 adults), MMWR (Nov 12, 2026) reported—and Nov 15 media amplified—that ~9.8% of adults used a GLP-1 in the past year; among users, ~22.6% took a compounded product and ~8.8% were unsure. About 44% reported modifying prescribed use (most often skipping doses, ~28%), commonly citing cost and availability; among modifiers aged 18–39, ~58% cited cost. Self-reported cross-sectional data cannot directly show downstream efficacy or safety after dose changes.
Links:
- CDC MMWR — GLP-1 use and modified use among U.S. adults
- Medical Daily — ~44% of users change how they take GLP-1s (Nov 15)
Commentary:
Discuss cost and supply problems with a clinician before skipping doses or switching to unreviewed compounded products—another reason resistance training matters during weight-loss pharmacotherapy.
IV. Sleep & Mental Health
8. Pediatric clinic review: atopic dermatitis linked to ~28% higher odds of sleep disturbance (sleep/allergy)
Summary:
A retrospective review of 26,395 patients aged 0–21 years (mean ~8.7; ~91% African American) from an urban primary-care clinic, presented at the 2026 ACAAI meeting and reported by Healio on Nov 15, found atopic dermatitis (AD) in ~14.5% and sleep disturbance in ~10.3%. Odds of sleep disturbance were higher with vs without AD (OR ~1.28; 95% CI 1.15–1.42); interactions with comorbid atopy or mental-health status were not significant. Electronic-record retrospectives and meeting abstracts limit causal inference and severity stratification.
Links:
Commentary:
When a child scratches at night or struggles to fall asleep, manage skin inflammation and sleep hygiene together—melatonin alone is not the plan.
9. RCT: both moderate-to-high-intensity and low-intensity “sham” resistance training sharply cut depressive symptoms in young women (mental health/training)
Summary:
University of Limerick investigators randomized 55 women aged 18–40 with analogue generalized anxiety disorder to 8 weeks of WHO/ACSM-style progressive moderate-to-high-intensity resistance training (~70%–80% 1RM) or 20% 1RM low-intensity sham; results appear in Journal of Affective Disorders (published Nov 15, 2026). Both arms showed large QIDS reductions maintained at one-month follow-up; the group×time interaction was nonsignificant (d≈0.17), though within-condition effects were larger for progressive RET (SMD ~1.53 vs ~1.04). The sample was modest, and the control still involved movement rather than sitting.
Links:
- University of Limerick — resistance training and depressive symptoms RCT record
- Journal of Affective Disorders — doi:10.1016/j.jad.2026.122228
Commentary:
Getting moving can itself deliver large mood benefits; progressive loading may add more, but severe depression still needs clinical care—training is not a replacement for treatment.
V. Evidence & Clarifications
10. Science Advances: in mice, long-chain saturated fats on ketogenic diets can drive proinflammatory macrophages via cGAS-STING (evidence clarification)
Summary:
University of Cincinnati researchers report in Science Advances that ketogenic diets rich in long-chain saturated fatty acids (e.g., palmitate, stearate) promote proinflammatory macrophage accumulation across heart, kidney, adipose, liver, and brain in mice; in culture, LC-SFAs pushed M1-like polarization while medium-chain or unsaturated fatty acids did not; myeloid Sting knockout blocked the proinflammatory phenotype. An isocaloric coconut-oil–based keto formula with lower LC-SFA content did not reproduce the same proinflammatory markers. This is animal/cell mechanism work and does not equal “all human keto causes systemic inflammation.”
Links:
Commentary:
If keto is medically indicated, fat quality (less LC-SFA stacking; room for unsaturated/medium-chain sources) deserves a clinical nutrition conversation—mouse findings should not scare every low-carb eater.
11. Waterloo maths model: post-meal vitamin C may curb gastric nitrosation—but is not human cancer-prevention evidence (evidence clarification)
Summary:
University of Waterloo investigators built a quantitative systems pharmacology model of nitrate/nitrite enterosalivary cycling and gastric chemistry in the Journal of Theoretical Biology, highlighted by ScienceDaily dated Nov 15. Simulations suggest dietary or post-meal vitamin C can moderately reduce nitrosation products linked to cancer risk, especially relevant for high-nitrite foods such as processed meats; leafy greens that co-contain nitrate and vitamin C may partly explain mixed epidemiology. Authors and the university emphasize that results are mathematical simulations, not proof of lower human cancer incidence.
Links:
- ScienceDaily — vitamin C and gastric nitrosation modelling (Nov 15)
- University of Waterloo — vitamin C may help prevent cancer (mechanism narrative)
- PubMed — Vitamin C as a nitrosation inhibitor (modelling study)
Commentary:
The practical takeaway remains “more produce vitamin C, less processed meat”—not treating a post-meal vitamin C tablet as a cancer prescription.
Today's Summary
- Diet: Green-MED tracked with pancreatic-fat loss; plant-milk swaps need iodine fortification scrutiny; very-low-energy diet plus supervised exercise raised early-onset T2D remission in a trial—but is not a DIY extreme protocol.
- Training: Resistance work is the lean-mass/strength partner to GLP-1–era weight loss; more high-intensity sets are not automatically better; proprioceptive training lowers ankle-injury risk.
- Public health & sleep: Real-world GLP-1 use is often altered for cost; pediatric eczema and sleep disturbance travel together; resistance training can sharply improve depressive symptoms within groups.
- Evidence boundaries: Keto inflammation mechanisms in mice hinge on fat type; vitamin C anti-nitrosation remains a model, not a clinical cancer endpoint.
Daily Framing:
Today in the sport/health/nutrition cycle was a “metabolic-organ fat + protect muscle while losing weight + micronutrient and evidence-boundary” day—pair Mediterranean patterns and resistance habits with the diabetes/obesity-drug era, while using iodine labels and animal/model limits to block overclaim.
This digest is compiled from real-time search results and is for reference only.